Skip to main content

Day: March 16, 2022

Investor Strategy Day

BRISBANE, Australia, March 16, 2022 (GLOBE NEWSWIRE) — Allkem Limited (ASX|TSX: AKE) (“Allkem” or “the Company”) is hosting a Strategy Day for investors on Tuesday, 5 April 2022. Managing Director and CEO, Mr. Martín Pérez de Solay and members of the executive team will provide a detailed presentation of the Company’s growth strategy. The webcast briefing will commence at 9:00 am AEST (Brisbane, Sydney, Melbourne time). Investors are invited to pre-register and view the webcast on Allkem’s website, www.allkem.co. Written questions may be submitted via the webcast and a recording will also be made available. This release was authorised by Mr Martin Perez de Solay, CEO and Managing Director of Allkem Limited.Allkem Limited ABN 31 112 589 910 Level 35, 71 Eagle StBrisbane, QLD 4000 Investor Relations & Media EnquiriesAndrew...

Continue reading

Reliq Health Technologies, Inc. Announces Five New Contracts in the US, Expansion of Mental Health Care Capabilities

HAMILTON, Ontario, March 16, 2022 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it has signed five new contracts with three primary care practices and two home health agencies in the US. The Company is also pleased to be expanding its mental health care capabilities beyond Behavioural Health Integration (BHI) to also support Collaborative Care Management (CoCM). “We are pleased to be adding these five new clients,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “These providers will add over 2,000 new patients to our iUGO Care platform. The contracts include a one-time payment...

Continue reading

WEST MINING ANNOUNCES FIRST PHASE OF 2022 EXPLORATION PROGRAM FOR THE KENA GOLD-COPPER PROJECT, BC

Vancouver, BC, March 16, 2022 (GLOBE NEWSWIRE) — West Mining Corp. (“West” or the “Company”) (CSE: WEST) (OTC: WESMF) is pleased to announce initial drill targets for the 2022 exploration program on its 100% owned Kena Gold-Copper project in southeastern British Columbia.  The over 9,000 hectare Kena Project, consists of the Kena, Daylight and Athabasca Properties which trend along a 20 kilometre long favourable mineralized belt. The 2022 exploration program will focus on various drill targets of which the first phase objective is the expansion of the gold resource, concentrating on high grade structures. The large Kena Property hosts several gold mineralized zones, most notably the Kena Gold and Gold Mountain, both included in the recent resource estimate hosting 2.77 million ounces of gold inferred and 0.56 million ounces of...

Continue reading

Proposed transfer of listing of Atari securities on Euronext Growth Paris Market

Proposed transfer of listing of Atari securities on Euronext Growth Paris Market Paris, March 16th, 2022 at 8:00am CET. On March 14th, the Board of Directors of Atari SA decided to submit to the approval of its shareholders the proposed transfer of listing of its securities from the regulated Euronext Paris market (Compartment C) to the Euronext Growth Paris market at the occasion of an Ordinary General Meeting to be held on April 20th. Reasons for the transfer This proposal aims to enable Atari to be admitted for trading on a market that is more adapted to the Company’s current market status, with simplified listing requirements and lighter reporting obligations than for the regulated market. Atari believes that the Euronext Growth Market will allow it to further focus its resources on the core business of the Company while remaining...

Continue reading

Proactive news headlines including Australian Vanadium, Latin Resources, Azure Minerals and Race Oncology

Sydney, March 16, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Australian Vanadium Ltd (ASX:AVL) soared up to 43% on securing a $49 million competitive grant from the Australian Federal Government under the Modern Manufacturing Initiative Collaboration Stream, to be used in the development of the Australian Vanadium Project. Click here Latin Resources Ltd (ASX:LRS) has discovered thick, spodumene-bearing pegmatites during its latest exploration campaign at the Salinas Lithium Project in Brazil with shares trading higher. Click here Azure Minerals Ltd (ASX:AZS) has landed a swag of strong results following drilling at Ridgeline nickel-copper sulphide prospect, with assays returning multiple high-grade nickel and copper...

Continue reading

03/2022・Trifork Group – 2021 annual report and interim report for the quarter ending 31 December 2021

Company announcement no. 3 / 2022Schindellegi, Switzerland – 16 March 2022Trifork Group reports revenue growth of 37.4% for 2021 and 21.2% in Q4 2021 Financial year 2021Trifork GroupIn 2021, Trifork Group revenue amounted to EURm 158.5, an increase by 37.4% from EURm 115.4 in 2020. Organic growth of 19.6% was mainly driven by high level of activity in Digital Health in Denmark and Fintech in the UK. Inorganic growth of EURm 20.5 came from the acquisitions of Nine A/S in September 2020, Vilea Group in May 2021 and Strongminds ApS in November 2021. Trifork Group EBITDA amounted to EURm 47.4. This included special items of EURm 22.1 from the deconsolidation of Dawn Health and IPO-preparation costs of EURm 1.8. Trifork Group EBIT amounted to EURm 35.6 compared to EURm 6.4 in 2020. Trifork Group net income was EURm 32.7 in 2021, compared...

Continue reading

Changes to the management board of Inbank

On 14 March 2022, the Supervisory Board of AS Inbank elected Ivar Kurvits as a member of the Management Board effective from 16 March 2022. The Supervisory Board also passed a decision to recall Benas Pavlauskas, Piret Paulus and Jaanus Kõusaar from their position as members of the Management Board effective 15 March 2022.  Ivar Kurvits will join the Management Board from his position as Head of HR and Legal at Inbank, where he has worked since 2016. In 2010–2015, he worked as General Counsel in Eesti Energia and between 2005–2009 as an Attorney at Law at Sorainen law firm. Ivar Kurvits owns 63,704 Inbank shares. His area of ​​responsibility as a member of the Management Board is the management of Inbank’s support units. Piret Paulus will take a 6-month sabbatical until 15 October 2022. The five-member Management Board of Inbank...

Continue reading

VGP and Allianz Joint Venture Completes €364 Million Logistics Portfolio Purchase  

Antwerp, Belgium, 16 March 2022 (7.00 a.m. CET) VGP NV (‘VGP’ or ‘the Company’) and Allianz Real Estate, acting on behalf of several Allianz Group companies, today announced a successful third closing with its 50:50 joint venture, VGP European Logistics II (‘Second Joint Venture’)1. The transaction comprised of 13 logistic buildings, including 9 buildings in 5 new VGP parks and another 4 newly completed logistic buildings which were developed in parks previously transferred to the Joint Venture. The 13 buildings are located in Spain (7), Italy (4), the Netherlands (1) and in Romania (1). The transaction value is € 364 million2. The gross proceeds from this transaction amounts to circa € 233 million3. The proceeds will be applied towards the further expansion of the development pipeline i.e. acquisition of new development...

Continue reading

New data for Roche’s Evrysdi (risdiplam) demonstrate long-term efficacy and safety in a broad population of people with spinal muscular atrophy (SMA)

Long-term efficacy data from the pivotal SUNFISH study confirm increases in motor function are sustained at three years while adverse events decreased over the same period Part 2 of SUNFISH showed Evrysdi demonstrated a marked improvement in, or stabilisation of, motor function after two years compared to an untreated external control group Latest interim results from the RAINBOWFISH study demonstrate that the majority of babies treated with Evrysdi for at least 12 months were able to stand and walk within timeframes typical of healthy babies More than 5,000 patients have been treated with Evrysdi to date, from newborns to people over 60 years of ageBasel, 16 March 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new data for Evrysdi® (risdiplam) in spinal muscular atrophy (SMA). Presentations included new three-year...

Continue reading

Ensu – Ex. reverse Share Split Today

Reference is made to the reverse share split that was approved by the Extraordinary General Meeting of Ensurge Micropower ASA (the “Company”) on 24 February 2022. Issuer name: Ensurge Micropower ASAEx. date: 16 March 2022Type of corporate action: Reverse share split For further information, please contact: Ståle Bjørnstad – Investor RelationsE-mail: stale.bjornstad@ensurge.com (mailto:stale.bjornstad@ensurge.com)Phone: +47 99 16 76 72 Kevin Barber – Chief Executive OfficerE-mail: kevin.barber@ensurge.com (mailto:kevin.barber@ensurge.com) This information is published in accordance with the requirements of the Continuing Obligations in Euronext Oslo Børs Rule Book II.

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.